When Cancer Council NSW set out to reduce smoking rates two decades ago, the team asked a question that would reshape everything: who is tobacco ...

Microaxial flow pump circulatory support with the Impella device during percutaneous coronary intervention (PCI) didn't help outcomes for complex patients not in cardiogenic shock, two randomized ...

In carefully selected patients with CTOs, symptom-driven PCI does provide a benefit when done by experienced operators.

At 52 weeks, the 30-mg daily oral dose of brepocitinib outperformed the 15-mg dose in a study of patients with dermatomyositis resistant to previous treatments.

The ALL-RISE Trial included 1930 patients enrolled across 59 global sites in North America, Asia, Europe and the Middle East. Patients presenting with coronary stenoses of intermediate significance ...

A study from researchers at The University of Texas at El Paso shows that just six weeks of boxing training can significantly reduce blood pressure and improve blood vessel function in young adults ...

This screenshot from an Abiomed video demonstrates placement of the Impella 2.5 and Impella CP. Delivered in a minimally invasive way, Impella pumps actively unload the heart, aiding native heart ...

Spread the loveIn recent years, the relationship between diet and mental health has garnered increasing attention, particularly among adolescents. A new study led by researchers from Swansea ...

Global randomized trial demonstrated statistically significant reduction in clinical event rates in patients with intermediate-risk PE when treated with the EKOS device plus anticoagulation vs. antico ...

The large dose of brepocitinib, a JAK1/TYK2 inhibitor, showed benefits on a composite score and secondary end points. The FDA has set a PDUFA date for the drug in the third quarter of 2026, according ...

(Catherine Delahaye/Getty Images) Rolling out a yoga mat and flowing with your breath could be one of the best exercises for improving sleep in the long run, according to recent research. A ...